DESCRIPTION (provided by applicant):
Diffraction enhanced imaging (DEI) is a novel approach to X-ray imaging which can revolutionize X -ray medical imaging, because of its greater contrast at lower X-ray doses than conventional radiography. DEI relies on X-ray optics of perfect crystals to acquire these images by measuring tiny angular deflections of a collimated X-ray beam as it pass es through the object (patient). T he use of DEl in clinical or laboratory settings will create an unprecedented market for perfect crystal X-ray optics, and this demand will overwhelm the capabilities and capacity of current crystal optics fabrication. The capability of DEI to detect low-density features in low-density matrices makes it especially useful in medical diagnoses and research. An essential prerequisite for optimizing DEI and using it with highly reproducible and predictable precision in a routine application such as medical applications is to have sufficiently large-area crystal optical elements. Our goal is to enable the application of DEI for laboratory imaging. We propose to: 1) design and test stable, reliable, large-area crystal optics (minimum of 250 mm x 100 mm) for much larger fields of view than are currently feasible, and 2) experimentally characterize the stability of the optics over extended periods of time as defined in Feasibility Criteria Standards further. We will test and evaluate the feasibility of two approaches for producing large-area crystal optics, which specifically are Single large-area crystals and Array of conventionally sized crystals. Based on the knowledge and the experience we have, we are confident that both approaches are realistic and feasible. The success of this proposed project will enable the U.S. to maintain leadership in the global competition in this area. At the completion of Phase 1, we anticipate the following results: 1. Working alpha prototypes of one or two large-area crystal optics produced under at least one of the two proposed approaches, and 2. Optics performance characterization in terms of stability, uniformity, size limitations, and range of operation as applied to DEI. Assuming favorable results from Phase 1, the objectives of a future Phase 2 project would be to: a) incorporate improvements and bull d a prototype commercial style large-size optics system that is sufficiently rugged, accurate, and economical to be commercially useful; b) determine whether the device could be produced at a reasonable cost, and c) develop means for making crystal optics fabrication on a large scale commercially feasible.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
X ray crystallographybioengineering /biomedical engineeringbioimaging /biomedical imagingimage enhancementoptics
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
832183748
UEI
Project Start Date
01-August-2004
Project End Date
31-October-2005
Budget Start Date
01-August-2004
Budget End Date
31-October-2005
Project Funding Information for 2004
Total Funding
$100,000
Direct Costs
$76,049
Indirect Costs
$19,012
Year
Funding IC
FY Total Cost by IC
2004
National Institute of Biomedical Imaging and Bioengineering
$100,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R41EB004303-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R41EB004303-01
Patents
No Patents information available for 1R41EB004303-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R41EB004303-01
Clinical Studies
No Clinical Studies information available for 1R41EB004303-01
News and More
Related News Releases
No news release information available for 1R41EB004303-01
History
No Historical information available for 1R41EB004303-01
Similar Projects
No Similar Projects information available for 1R41EB004303-01